391 related articles for article (PubMed ID: 10493848)
1. D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction.
Tataru MC; Heinrich J; Junker R; Schulte H; von Eckardstein A; Assmann G; Koehler E
Eur Heart J; 1999 Oct; 20(20):1493-502. PubMed ID: 10493848
[TBL] [Abstract][Full Text] [Related]
2. Plasma fibrinogen in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction.
Tataru MC; Schulte H; von Eckardstein A; Heinrich J; Assmann G; Koehler E
Coron Artery Dis; 2001 May; 12(3):157-65. PubMed ID: 11352071
[TBL] [Abstract][Full Text] [Related]
3. Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina?
Itakura H; Sobel BE; Boothroyd D; Leung LL; Iribarren C; Go AS; Fortmann SP; Quertermous T; Hlatky MA;
Am Heart J; 2007 Dec; 154(6):1059-64. PubMed ID: 18035075
[TBL] [Abstract][Full Text] [Related]
4. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain.
Heinrich J; Schulte H; Schönfeld R; Köhler E; Assmann G
Thromb Haemost; 1995 Mar; 73(3):374-9. PubMed ID: 7667818
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris.
Tataru MC; Heinrich J; Junker R; Schulte H; von Eckardstein A; Assmann G; Koehler E
Eur Heart J; 2000 Jun; 21(12):1000-8. PubMed ID: 10901512
[TBL] [Abstract][Full Text] [Related]
6. Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study.
Cushman M; Lemaitre RN; Kuller LH; Psaty BM; Macy EM; Sharrett AR; Tracy RP
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):493-8. PubMed ID: 10073948
[TBL] [Abstract][Full Text] [Related]
7. Plasma fibrin D-dimer levels and risk of stable coronary artery disease: results of a large case-control study.
Koenig W; Rothenbacher D; Hoffmeister A; Griesshammer M; Brenner H
Arterioscler Thromb Vasc Biol; 2001 Oct; 21(10):1701-5. PubMed ID: 11597948
[TBL] [Abstract][Full Text] [Related]
8. Tissue plasminogen activator and plasminogen activator inhibitor-1 levels in patients with acute myocardial infarction and unstable angina.
Habib SS; Abdel Gader AG; Kurdi MI; Suriya MO; Al Aseri Z
J Pak Med Assoc; 2012 Jul; 62(7):681-5. PubMed ID: 23866515
[TBL] [Abstract][Full Text] [Related]
9. Fibrinogen and fibrinolysis in blood and in the arterial wall: its role in advanced atherosclerotic disease.
Martin-Paredero V; Vadillo J; Diaz J; Espinosa A; Berga C; Segura J; Sanchez J; Barbod A; Villaverde C; Richard CM
Cardiovasc Surg; 1998 Oct; 6(5):457-62. PubMed ID: 9794264
[TBL] [Abstract][Full Text] [Related]
10. Comparison of plasminogen activator inhibitor-1, tissue type plasminogen activator antigen, fibrinogen, and D-dimer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease (from the BARI 2D trial).
McBane RD; Hardison RM; Sobel BE;
Am J Cardiol; 2010 Jan; 105(1):17-24. PubMed ID: 20102884
[TBL] [Abstract][Full Text] [Related]
11. [Evolution of fibrinolysis status with D-dimer level and the rate of plasminogen activator inhibitor type-1/D-dimer in acute coronary syndrome patients complicated with impaired glucose tolerance].
Wu WD; Xu YH; Tan PY
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Aug; 15(8):472-5. PubMed ID: 12919647
[TBL] [Abstract][Full Text] [Related]
12. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
van der Bom JG; Bots ML; Haverkate F; Meyer P; Hofman A; Grobbee DE; Kluft C
Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006
[TBL] [Abstract][Full Text] [Related]
13. Activation of coagulation and fibrinolysis in patients with arteriosclerosis: relation to localization of vessel disease and risk factors.
Speiser W; Speiser P; Minar E; Korninger C; Niessner H; Huber K; Schernthaner G; Ehringer H; Lechner K
Thromb Res; 1990 Jul; 59(1):77-88. PubMed ID: 2144671
[TBL] [Abstract][Full Text] [Related]
14. Fibrinolytic activity in coronary heart disease.
Yao SK; Chen ZJ; Tao SQ
Chin Med J (Engl); 1989 Sep; 102(9):660-3. PubMed ID: 2517077
[TBL] [Abstract][Full Text] [Related]
15. Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis.
Eisenberg PR; Jaffe AS; Stump DC; Collen D; Bovill EG
Circulation; 1990 Oct; 82(4):1159-68. PubMed ID: 2119264
[TBL] [Abstract][Full Text] [Related]
16. D-dimer plasma levels in NSTE-ACS patient.
Charoensri N; Pornratanarangsi S
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S39-45. PubMed ID: 21721427
[TBL] [Abstract][Full Text] [Related]
17. Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men.
Wannamethee SG; Whincup PH; Shaper AG; Rumley A; Lennon L; Lowe GD
J Thromb Haemost; 2009 Oct; 7(10):1605-11. PubMed ID: 19682232
[TBL] [Abstract][Full Text] [Related]
18. D-dimer and fibrinolysis in patients with various degrees of atherosclerosis.
Panchenko E; Dobrovolsky A; Davletov K; Titaeva E; Kravets A; Podinovskaya J; Karpov Y
Eur Heart J; 1995 Jan; 16(1):38-42. PubMed ID: 7737219
[TBL] [Abstract][Full Text] [Related]
19. D-dimer local expression is increased in symptomatic patients undergoing carotid endarterectomy.
Krupinski J; Catena E; Miguel M; Domenech P; Vila R; Morchon S; Rubio F; Cairols M; Slevin M; Badimon L
Int J Cardiol; 2007 Mar; 116(2):174-9. PubMed ID: 16901564
[TBL] [Abstract][Full Text] [Related]
20. Plasma fibrinogen, fibrinolytic activity and serum fibrinogen/fibrin degradation products in ischaemic heart disease.
Dube B; Somani PN; Tripathi GK; Dube RK; Bhattacharya SK
J Assoc Physicians India; 1985 Dec; 33(12):784-5, 787. PubMed ID: 3837002
[No Abstract] [Full Text] [Related]
[Next] [New Search]
